In the last one month stocks from different sectors have seen an improvement in their analyst scores. The selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating)’s stock price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $9.08 and last traded at $9.08, with a volume of 202576 shares changing hands. The stock had previously closed at $9.07. Analyst Ratings Changes Several brokerages recently issued reports […]
ABVC BioPharma, Inc. (OTCMKTS:ABVC – Get Rating) dropped 8% on Monday . The company traded as low as $0.61 and last traded at $0.61. Approximately 29,815 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 506,125 shares. The stock had previously closed at $0.67. ABVC BioPharma Stock Performance […]
StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research report report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms also recently weighed in on CTIC. TD Cowen dropped their price target on shares of CTI BioPharma from […]
CTI BioPharma (NASDAQ: CTIC) recently received a number of ratings updates from brokerages and research firms: 5/26/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/18/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/16/2023 […]